联影医疗(688271):25Q2营收同比增长19%,国内业务稳步复苏

Investment Rating - The investment rating for the company is "Outperform the Market" [5][19]. Core Views - The company's performance is showing a recovery driven by the rebound in the domestic bidding market, with significant growth in overseas markets. The revenue forecast for 2025-2027 has been raised, expecting revenues of 124.1 billion, 145.1 billion, and 169.4 billion respectively, with year-on-year growth rates of 20.4%, 16.9%, and 16.8% [3][19]. Financial Performance - In the first half of 2025, the company achieved revenue of 60.16 billion yuan, a year-on-year increase of 12.79%, and a net profit of 9.98 billion yuan, up 5.03%. In Q2 2025 alone, revenue reached 35.38 billion yuan, growing by 18.60% year-on-year [1][8]. - The revenue from equipment sales in the first half of 2025 was 48.9 billion yuan, reflecting a 7.6% increase, while the maintenance service business grew rapidly, generating 8.16 billion yuan in revenue, a 32.2% increase [1][13]. Market Segmentation - The domestic market generated 48.7 billion yuan in revenue in the first half of 2025, up 10.7%, benefiting from accelerated equipment update policies and a significant recovery in the bidding market. The overseas market saw revenue of 11.4 billion yuan, a remarkable increase of 22.5%, with revenue contribution rising to 19% [2][13]. Profitability and Cost Control - The company's gross margin for the first half of 2025 was 47.93%, a slight decrease of 2.45 percentage points, primarily due to price competition from centralized procurement. However, all expense ratios, including sales, management, R&D, and financial expenses, showed a decline, indicating effective cost control [2][18]. Earnings Forecast - The forecast for net profit for 2025-2027 has been adjusted to 19.5 billion, 23.7 billion, and 27.7 billion yuan respectively, with corresponding year-on-year growth rates of 54.5%, 21.7%, and 16.7% [3][19]. Valuation Metrics - The current stock price corresponds to a price-to-earnings (PE) ratio of 64, 53, and 45 for the years 2025, 2026, and 2027 respectively [3][19].